Nalu Medical

Executive Summary

Nalu Medical is a privately held medical device company based in Carlsbad, California, pioneering a next-generation neurostimulation therapy for chronic nerve pain. Founded in 2015, the company has developed the Nalu Neurostimulation System—a miniaturized, battery-free implant designed to deliver long-term, drug-free pain relief for patients with intractable pain. The device eliminates the need for bulky implantable pulse generators and frequent battery replacements, addressing key limitations of existing neurostimulation systems. With regulatory approval already secured, Nalu is positioned to disrupt the $6B+ neurostimulation market, offering a differentiated, patient-friendly solution that reduces surgical invasiveness and improves patient outcomes. The company is led by an experienced team of medical device executives and has garnered industry awards for its innovative technology. Nalu Medical's immediate focus is on commercial launch and market penetration, targeting pain management specialists and spine centers. The company aims to leverage its technology's unique advantages—full-body MRI compatibility, miniature size, and durability—to capture share from incumbents like Medtronic and Abbott. Key catalysts include initial sales traction and reimbursement wins, which will validate the commercial model and potentially attract strategic partnership or acquisition interest from larger players seeking to expand their neurostimulation portfolios. As a private company with an approved product, Nalu represents a compelling late-stage investment opportunity in the medical device space.

Upcoming Catalysts (preview)

• Q3 2026Initial Commercial Sales Results and Reimbursement Milestones70% success
• Q4 2026Strategic Partnership or Licensing Agreement with a Major Medical Device Company60% success
• TBDExpansion of Indications to Include New Pain Conditions (e.g., diabetic neuropathy)30% success